• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUMO 特异性蛋白酶 2 介导的去 SUMOylation 对于胃癌细胞中 NDRG2 的稳定是必需的。

SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.

机构信息

Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.

Gastrointestinal Endoscope Center, Cancer Hospital of Guizhou Medical University, Guiyang 550001, Guizhou, China.

出版信息

Cancer Biomark. 2017 Dec 12;21(1):195-201. doi: 10.3233/CBM-170651.

DOI:10.3233/CBM-170651
PMID:29060933
Abstract

N-myc downstream regulated gene 2 (NDRG2) is frequently down-regulated in various cancers and functions as a candidate tumor suppressor gene. NDRG2 has been shown to be SUMOylated on the lysine 333 residue, which promoted its ubiquitination and sequentially degradation by the SUMO-targeted ubiquitin E3 ligase RNF4. However, how to regulated NDRG2 deSUMOylation process remains largely unknown. Here, we report that Sentrin/SUMO specific protease (SENP2) was down-regulated in clinic gastric cancer samples and possessed a tumor-suppressive role in gastric cancer. At the molecular level, we found that SENP2 interacts with NDRG2 and mediates the de-SUMOylation process of NDRG2. Overexpression of SENP2 stabilized NDRG2, whereas silencing SENP2 caused rapid NDRG2 SUMOylation and degradation, indicating SENP2 antagonizes NDRG2 ubiquitination and degradation, thereby promoting the stability and function of this protein. Thus, our study reveals that SENP2 acts as a tumor suppressor which is deregulated in gastric cancer and the specific de-SUMOylation activity of SENP2 for NDRG2 is critical for it stabilization as well as gastric cancer cells proliferation.

摘要

N- myc 下游调节基因 2(NDRG2)在各种癌症中经常下调,作为候选肿瘤抑制基因发挥作用。已证实 NDRG2 在赖氨酸 333 残基上发生 SUMO 化,促进其泛素化,并通过 SUMO 靶向泛素 E3 连接酶 RNF4 进行顺序降解。然而,NDRG2 的去 SUMO 化过程如何调节仍知之甚少。在这里,我们报告 Sentrin/SUMO 特异性蛋白酶(SENP2)在临床胃癌样本中下调,并在胃癌中具有肿瘤抑制作用。在分子水平上,我们发现 SENP2 与 NDRG2 相互作用,并介导 NDRG2 的去 SUMO 化过程。SENP2 的过表达稳定了 NDRG2,而沉默 SENP2 导致 NDRG2 的 SUMO 化和快速降解,表明 SENP2 拮抗 NDRG2 的泛素化和降解,从而促进该蛋白的稳定性和功能。因此,我们的研究表明,SENP2 作为一种肿瘤抑制因子在胃癌中失调,SENP2 对 NDRG2 的特异性去 SUMO 化活性对其稳定以及胃癌细胞的增殖至关重要。

相似文献

1
SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.SUMO 特异性蛋白酶 2 介导的去 SUMOylation 对于胃癌细胞中 NDRG2 的稳定是必需的。
Cancer Biomark. 2017 Dec 12;21(1):195-201. doi: 10.3233/CBM-170651.
2
RNF4-mediated SUMOylation is essential for NDRG2 suppression of lung adenocarcinoma.RNF4介导的SUMO化修饰对于NDRG2抑制肺腺癌至关重要。
Oncotarget. 2016 May 3;7(18):26837-43. doi: 10.18632/oncotarget.8663.
3
SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.SENP3通过拮抗SUMO2/3靶向的泛素化和降解来调节整体蛋白质周转和Sp1水平。
Protein Cell. 2016 Jan;7(1):63-77. doi: 10.1007/s13238-015-0216-7. Epub 2015 Oct 28.
4
The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.EB 病毒致癌蛋白,LMP1,调节 SUMO 蛋白酶 SENP2 的功能。
Sci Rep. 2019 Jul 2;9(1):9523. doi: 10.1038/s41598-019-45825-5.
5
SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.SENP2通过去SUMO化修饰转化生长因子-β受体I(TGF-βRI)抑制膀胱癌细胞的上皮-间质转化。
Mol Carcinog. 2017 Oct;56(10):2332-2341. doi: 10.1002/mc.22687. Epub 2017 Jun 30.
6
SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1.SUMO特异性蛋白酶6通过去SUMO化修饰FoxM1促进胃癌细胞生长。
Tumour Biol. 2015 Dec;36(12):9865-71. doi: 10.1007/s13277-015-3737-z. Epub 2015 Jul 12.
7
The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.E3 泛素连接酶 APC/C-Cdh1 通过将 SUMO 特异性蛋白酶 2 靶向泛素化和降解来调节 MEF2A 依赖性转录。
Cell Cycle. 2014;13(24):3892-902. doi: 10.4161/15384101.2014.973302.
8
SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.SUMO特异性蛋白酶2通过抑制膀胱癌细胞中MMP13的表达来抑制细胞迁移和侵袭。
Cell Physiol Biochem. 2013;32(3):542-8. doi: 10.1159/000354458. Epub 2013 Aug 30.
9
SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell.在肝癌细胞中,SENP2通过WWOX调节β-连环蛋白的稳定性。
Tumour Biol. 2014 Oct;35(10):9677-82. doi: 10.1007/s13277-014-2239-8. Epub 2014 Jun 27.
10
SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.SENP2 通过去 SUMO 化 IRF3 使其泛素化和降解来负调控细胞抗病毒反应。
J Mol Cell Biol. 2011 Oct;3(5):283-92. doi: 10.1093/jmcb/mjr020.

引用本文的文献

1
Construction and validation of a post-translational modification-related signature to predict the effect of immune therapies in gastric cancer.用于预测免疫治疗在胃癌中疗效的翻译后修饰相关特征的构建与验证
Biochem Biophys Rep. 2025 Jul 14;43:102146. doi: 10.1016/j.bbrep.2025.102146. eCollection 2025 Sep.
2
Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer.长链非编码RNA-MIR181A1HG作为一种癌基因,促进胃癌的侵袭和转移。
Oncogene. 2025 Jun;44(20):1517-1529. doi: 10.1038/s41388-025-03323-1. Epub 2025 Mar 5.
3
Role of non-canonical post-translational modifications in gastrointestinal tumors.
非经典翻译后修饰在胃肠道肿瘤中的作用。
Cancer Cell Int. 2023 Sep 30;23(1):225. doi: 10.1186/s12935-023-03062-x.
4
The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.SUMO化修饰在肿瘤微环境中的新作用及治疗意义。
Exp Hematol Oncol. 2023 Jul 6;12(1):58. doi: 10.1186/s40164-023-00420-3.
5
SUMOylation of TUFT1 is essential for gastric cancer progression through AKT/mTOR signaling pathway activation.SUMOylation 修饰 TUFT1 通过激活 AKT/mTOR 信号通路促进胃癌进展。
Cancer Sci. 2023 Feb;114(2):533-545. doi: 10.1111/cas.15618. Epub 2022 Nov 15.
6
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.癌症相关的 SUMO 调节因子失调:蛋白酶和连接酶。
Int J Mol Sci. 2022 Jul 20;23(14):8012. doi: 10.3390/ijms23148012.
7
SENP2 Reduces Hepatocellular Carcinoma Stemness and Improves Sorafenib Sensitivity Through Inactivating the AKT/GSK3β/CTNNB1 Pathway.SENP2通过使AKT/GSK3β/CTNNB1信号通路失活降低肝癌干细胞特性并提高索拉非尼敏感性。
Front Oncol. 2021 Dec 7;11:773045. doi: 10.3389/fonc.2021.773045. eCollection 2021.
8
Astrocyte-specific NDRG2 gene: functions in the brain and neurological diseases.星形胶质细胞特异性 NDRG2 基因:在大脑和神经疾病中的功能。
Cell Mol Life Sci. 2020 Jul;77(13):2461-2472. doi: 10.1007/s00018-019-03406-9. Epub 2019 Dec 13.
9
Regulation of post-translational modification in breast cancer treatment.乳腺癌治疗中的翻译后修饰调控。
BMB Rep. 2019 Feb;52(2):113-118. doi: 10.5483/BMBRep.2019.52.2.017.
10
SUMO-specific protease 2 (SENP2) functions as a tumor suppressor in osteosarcoma via SOX9 degradation.小泛素样修饰特异性蛋白酶2(SENP2)通过降解SOX9在骨肉瘤中发挥肿瘤抑制作用。
Exp Ther Med. 2018 Dec;16(6):5359-5365. doi: 10.3892/etm.2018.6838. Epub 2018 Oct 9.